551–600 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
551	CUL3	cullin 3	2	TransporterOMIM Disease Gene	481
552	TRPV1	transient receptor potential cation channel subfamily V member 1	17	Ion ChannelTransporter	481
553	GH1	growth hormone 1	17	OMIM Disease GeneHighly Studied	480
554	WNT5A	Wnt family member 5A	3	OMIM Disease GeneHighly Studied	480
555	CDK6	cyclin dependent kinase 6	7	KinaseFDA Approved Target	479
556	CDKN2B	cyclin dependent kinase inhibitor 2B	9	Tumor SuppressorHighly Studied	479
557	IFNB1	interferon beta 1	9	Clinical TrialsHighly Studied	479
558	IL4R	interleukin 4 receptor	16	ReceptorFDA Approved Target	479
559	PRMT1	protein arginine methyltransferase 1	19	Highly ConstrainedHighly Studied	479
560	CANX	calnexin	5	Highly ConstrainedHighly Studied	478
561	HAMP	hepcidin antimicrobial peptide	19	Early PipelineOMIM Disease Gene	477
562	KLK3	kallikrein related peptidase 3	19	ProteaseFDA Approved Target	477
563	LYN	LYN proto-oncogene, Src family tyrosine kinase	8	Highly ConstrainedKinase	475
564	PHB1	prohibitin 1	17	OncogeneHighly Studied	475
565	EPO	erythropoietin	7	OMIM Disease GeneHighly Studied	474
566	ITGA2	integrin subunit alpha 2	5	ReceptorClinical Trials	473
567	SELE	selectin E	1	Clinical TrialsHighly Studied	473
568	TTN	titin	2	KinaseOMIM Disease Gene	472
569	FGB	fibrinogen beta chain	4	FDA Approved TargetOMIM Disease Gene	471
570	SREBF1	sterol regulatory element binding transcription factor 1	17	Transcription FactorOMIM Disease Gene	471
571	TET2	tet methylcytosine dioxygenase 2	4	Tumor SuppressorOMIM Disease Gene	471
572	SMN1	survival of motor neuron 1, telomeric	5	FDA Approved TargetOMIM Disease Gene	470
573	APOC3	apolipoprotein C3	11	TransporterFDA Approved Target	469
574	CD209	CD209 molecule	19	ReceptorHighly Studied	469
575	GLI1	GLI family zinc finger 1	12	OncogeneOMIM Disease Gene	468
576	RARA	retinoic acid receptor alpha	17	Highly ConstrainedOncogene	466
577	CTCF	CCCTC-binding factor	16	Highly ConstrainedTranscription Factor	465
578	MEFV	MEFV innate immunity regulator, pyrin	16	OMIM Disease GeneHighly Studied	465
579	TP53BP1	tumor protein p53 binding protein 1	15	DNA RepairHighly Studied	465
580	IL12A	interleukin 12A	3	FDA Approved TargetHighly Studied	464
581	CASP9	caspase 9	1	ApoptosisProtease	463
582	CDK5	cyclin dependent kinase 5	7	KinaseClinical Trials	463
583	DNM1L	dynamin 1 like	12	OMIM Disease GeneHighly Studied	463
584	IQGAP1	IQ motif containing GTPase activating protein 1	15	Highly StudiedExperimental GO Evidence	463
585	PTPN6	protein tyrosine phosphatase non-receptor type 6	12	Highly ConstrainedHighly Studied	463
586	RPS3	ribosomal protein S3	11	DNA RepairHighly Constrained	463
587	APOA5	apolipoprotein A5	11	TransporterOMIM Disease Gene	462
588	FLG	filaggrin	1	OMIM Disease GeneHighly Studied	461
589	VKORC1	vitamin K epoxide reductase complex subunit 1	16	FDA Approved TargetOMIM Disease Gene	461
590	ACTA1	actin alpha 1, skeletal muscle	1	OMIM Disease GeneHighly Studied	460
591	CTNND1	catenin delta 1	11	Highly ConstrainedOMIM Disease Gene	459
592	HAVCR2	hepatitis A virus cellular receptor 2	5	FDA Approved TargetOMIM Disease Gene	459
593	AIFM1	apoptosis inducing factor mitochondria associated 1	X	ApoptosisHighly Constrained	458
594	NEDD4	NEDD4 E3 ubiquitin protein ligase	15	Highly StudiedExperimental GO Evidence	458
595	PLCG1	phospholipase C gamma 1	20	OMIM Disease GeneHighly Studied	458
596	PPP1CA	protein phosphatase 1 catalytic subunit alpha	11	Highly StudiedExperimental GO Evidence	458
597	RUVBL1	RuvB like AAA ATPase 1	3	DNA RepairHighly Constrained	458
598	ATP2A2	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	12	Highly ConstrainedTransporter	455
599	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	3	Highly ConstrainedOMIM Disease Gene	455
600	MTDH	metadherin	8	Highly StudiedExperimental GO Evidence	455